TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older. It is not known if TAKHZYRO is safe and effective in children under 12 years of age.

REIMAGINE YOUR LIFE WITH HAE

I want to reimagine:

Not an actual patient.

Image of a marked calendar. Reimagine your dosing schedule with TAKHZYRO.

Reimagine your dosing schedule

TAKHZYRO is a subcutaneous (under-the-skin) injection you give yourself once every 2 weeks.

Learn about dosing

The recommended dose is 300 mg
every 2 weeks for people starting on TAKHZYRO.

Not an actual patient.

SELECT IMPORTANT SAFETY INFORMATION

The most common side effects seen with TAKHZYRO were injection site reactions (pain, redness, and bruising), upper respiratory infection, and headache.

These are not all the possible side effects of TAKHZYRO. For more information, ask your healthcare provider or pharmacist. You may report side effects to the FDA at 1–800–FDA–1088.

Image of a marked calendar. Reimagine your dosing schedule with TAKHZYRO.

Reimagine your life with fewer attacks

People taking TAKHZYRO in a clinical study had attacks less often, and some people in the study had zero attacks.

In a 26-week clinical trial of 125 people with HAE 12 years of age and older, TAKHZYRO significantly reduced the number of monthly attacks, compared with placebo. People taking TAKHZYRO also had fewer moderate or severe attacks and fewer attacks requiring acute treatment, compared with placebo. And according to a supportive analysis, there were people taking TAKHZYRO who had zero attacks during the entire trial.

FIND OUT MORE
Image of a woman walking confidently. Reimagine your life with fewer HAE attacks.

Not an actual patient.

SELECT IMPORTANT SAFETY INFORMATION

TAKHZYRO may cause serious side effects, including allergic reactions. Call your healthcare provider or get emergency help right away if you have any of the following symptoms:

  • wheezing
  • difficulty breathing
  • chest tightness
  • fast heartbeat
  • faintness
  • rash
  • hives
Image of speech bubbles. Talk to your healthcare provider about TAKHZYRO.

Talk to your healthcare provider about TAKHZYRO

We’ll help you get started.

Check out the Discussion Guide

Personalized product support every step of the way

The OnePath® program helps people aged 12 years and older who have been prescribed TAKHZYRO get access to their medication.

GET THE DETAILS

WHAT IS TAKHZYRO?

TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older.

It is not known if TAKHZYRO is safe and effective in children under 12 years of age.

IMPORTANT SAFETY INFORMATION

TAKHZYRO may cause serious side effects, including allergic reactions. Call your healthcare provider or get emergency help right away if you have any of the following symptoms:

  • wheezing
  • difficulty breathing
  • chest tightness
  • fast heartbeat
  • faintness
  • rash
  • hives

The most common side effects seen with TAKHZYRO were injection site reactions (pain, redness, and bruising), upper respiratory infection, and headache.

These are not all the possible side effects of TAKHZYRO. For more information, ask your healthcare provider or pharmacist. You may report side effects to the FDA at 1–800–FDA–1088.

TAKHZYRO has not been studied in pregnant or breastfeeding women. Talk to your healthcare provider about the risk of taking TAKHZYRO if you are pregnant, plan to be pregnant, are breastfeeding, or plan to breastfeed.

Please see full Prescribing Information, including information for patients.